Position in EVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,988
+$5,008 QoQ
Shares Held
8,210
+14.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 34 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UMB Bank, n.a. holds $3,089,052 across 25 Drug Manufacturers - Specialty & Generic names. EVO ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,833 | $994,038 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,342 | $727,135 | |
| 3 | VTRS |
Viatris Inc
|
16,344 | $259,542 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,317 | $221,967 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
6,187 | $152,262 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,844 | $130,234 | |
| 7 | HLN |
Haleon plc
|
12,835 | $119,750 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,012 | $112,271 |
All Filings in EVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,988 | 8,210 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $17,980 | 7,192 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $29,494 | 9,576 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $40,430 | 11,138 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $55,923 | 13,315 | Shares | Defined | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||